[{"Assets_0_Q2_USD":"1556600000.0","CIK":"899923","CommonStockSharesIssued_0_Q2_shares":"73200000.0","CommonStockSharesOutstanding_0_Q2_shares":"73200000.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"0.04","EarningsPerShareBasic_2_Q2_USD":"0.03","EarningsPerShareDiluted_1_Q2_USD":"0.03","EarningsPerShareDiluted_2_Q2_USD":"0.02","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","MinorityInterest_0_Q2_USD":"-100000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"45600000.0","NetIncomeLoss_1_Q2_USD":"2600000.0","NetIncomeLoss_2_Q2_USD":"1900000.0","OfficialName":"Myriad Genetics Inc. Common Stock","ProfitLoss_1_Q2_USD":"2600000.0","ProfitLoss_2_Q2_USD":"1800000.0","RevenuesConverted_1_Q2_USD":"216800000.0","RevenuesConverted_2_Q2_USD":"419100000.0","SP500":null,"Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"1064100000.0","StockholdersEquity_0_Q2_USD":"1064200000.0","Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"76500000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"76900000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"74200000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"73600000.0","filed":"20190206","footnote":null,"form":"10-Q","fp":"Q2","fy":"2019.0","name":"MYRIAD GENETICS INC","period":"20181231","qtrs":"0","uom":"USD"}]